Clinical Trials Browser

Terminated × icotinib × Clear all

NCT01996098 2024-09-05

ICTAN

Phase 3 Terminated

Lung Neoplasms

NCT02362230 2021-01-29

Evaluation of Icotinib in Metastatic Triple-negative Breast Cancer After Second-line Therapy

Phase 2 Terminated

Breast Neoplasms